En af undersøgelserne så især nærmere på patienter med unormalt højt fedtindhold i blodet, og en anden så nærmere på patienter med type 2- diabetes.
Four studies of ZIMULTI in overweight and obese patients were carried out, involving almost 7,000 patients, whose weight at the start of the studies was on average 94 to 104 kg.